22,051 Shares in Ingevity Corporation $NGVT Bought by CWA Asset Management Group LLC

CWA Asset Management Group LLC purchased a new stake in Ingevity Corporation (NYSE:NGVT) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 22,051 shares of the company’s stock, valued at approximately $1,305,000. CWA Asset Management Group LLC owned approximately 0.06% of Ingevity at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. AQR Capital Management LLC grew its stake in shares of Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock valued at $518,000 after buying an additional 1,323 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Ingevity by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock worth $863,000 after acquiring an additional 1,080 shares in the last quarter. Empowered Funds LLC boosted its holdings in Ingevity by 12.9% in the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock worth $205,000 after acquiring an additional 594 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Ingevity by 311.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after acquiring an additional 454,579 shares during the period. Finally, Jane Street Group LLC grew its position in Ingevity by 306.1% in the first quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock valued at $3,519,000 after acquiring an additional 66,995 shares in the last quarter. 91.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on NGVT shares. BMO Capital Markets reiterated an “outperform” rating and set a $83.00 price objective on shares of Ingevity in a research note on Monday, March 2nd. Zacks Research raised shares of Ingevity to a “hold” rating in a report on Tuesday, December 16th. Wells Fargo & Company lifted their price target on shares of Ingevity from $65.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a report on Monday, March 9th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research report on Thursday, January 22nd. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Ingevity presently has a consensus rating of “Hold” and an average price target of $80.00.

Ingevity Stock Down 2.8%

Shares of NYSE:NGVT opened at $63.54 on Monday. The firm has a market cap of $2.24 billion, a PE ratio of -13.66 and a beta of 1.31. The company has a fifty day simple moving average of $68.95 and a 200 day simple moving average of $60.23. The company has a current ratio of 1.33, a quick ratio of 0.79 and a debt-to-equity ratio of 39.10. Ingevity Corporation has a 12-month low of $28.49 and a 12-month high of $77.46.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.16). The company had revenue of $255.10 million for the quarter, compared to the consensus estimate of $257.27 million. Ingevity had a negative net margin of 13.51% and a positive return on equity of 126.25%. The company’s revenue was down 3.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.95 earnings per share. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. On average, equities research analysts anticipate that Ingevity Corporation will post 4.45 EPS for the current fiscal year.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.